F Negro
Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
Goossens N, Semmo N, Mullhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group. Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review. J Viral Hepat 2018; 25:920-929.
Apr 17, 2018Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review
Apr 17, 2018J Viral Hepat 2018; 25:920-929
Goossens N, Semmo N, Mullhaupt B, Semela David, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F, Wedemeyer H, Adinolfi L E, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, BOSTIC Study Group
Trends in hepatitis C-related mortality in Switzerland
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela D, Terziroli B, Bruggmann P, Moradpour D, Dufour J, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort. Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat 2017; 25:152-160.
Nov 20, 2017Trends in hepatitis C-related mortality in Switzerland
Nov 20, 2017J Viral Hepat 2017; 25:152-160
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela David, Terziroli B, Bruggmann P, Moradpour D, Dufour J-F, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort
Impact of common risk factors of fibrosis progression in chronic hepatitis C
Rüeger S, Halfon P, Bourlière M, Talal A, Jacobson I, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Argiro L, George J, Bochud P, Dufour J, Mullhaupt B, Semela D, Heim M, Moradpour D, Cerny A, Malinverni R, Booth D, Suppiah V, Negro F. Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut 2014
Sep 11, 2014Impact of common risk factors of fibrosis progression in chronic hepatitis C
Sep 11, 2014Gut 2014
Rüeger S, Halfon P, Bourlière M, Talal A H, Jacobson I M, Patin E, Nalpas B, Poynard T, Pol S, Abel L, Kutalik Z, Argiro L, George J, Bochud P-Y, Dufour J-F, Mullhaupt B, Semela David, Heim M H, Moradpour D, Cerny A, Malinverni R, Booth D R, Suppiah V, Negro F
Strategies to manage hepatitis C virus (HCV) disease burden
Kautz A, Myers R, Nemecek V, Øvrehus A, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Roberts S, Mullhaupt B, Moreno C, Mendes Correa M, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha G, Sperl J, Stärkel P, Stauber R, Thompson A, Gower E, Kaita K, Wedemeyer H, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Calinas F, Calleja J, Cheinquer H, Christensen P, Berg T, Balık I, Aleman S, Duberg A, Buti M, Rosenberg W, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H, Gerstoft J, Giria J, Gonçales F, Guimarães Pessôa M, Hézode C, Hindman S, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P, Ferraz M, Cornberg M, Cramp M, Dore G, Doss W, El-Sayed M, Ergör G, Estes C, Falconer K, Félix J, Kåberg M. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21 Suppl 1:60-89.
May 1, 2014Strategies to manage hepatitis C virus (HCV) disease burden
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:60-89
Kautz A, Myers R P, Nemecek V, Øvrehus A L H, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Roberts S K, Mullhaupt B, Moreno C, Mendes Correa M C, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R T, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S D, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela David, Sherman M, Shiha G E, Sperl J, Stärkel P, Stauber R E, Thompson A J, Gower E, Kaita K D E, Wedemeyer H, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Berg T, Balık I, Aleman S, Duberg A S, Buti M, Rosenberg W M, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H S M, Gerstoft J, Giria J A, Gonçales F L, Guimarães Pessôa M, Hézode C, Hindman S J, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P R, Ferraz M L G, Cornberg M, Cramp M E, Dore G J, Doss W, El-Sayed M H, Ergör G, Estes C, Falconer K, Félix J, Kåberg M
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Kaita K, Nemecek V, Örmeci N, Øvrehus A, Parkes J, Pasini K, Peltekian K, Ramji A, Reis N, Roberts S, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R, Marotta P, Mauss S, Rosenberg W, Roudot-Thoraval F, Ryder S, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela D, Sherman M, Shiha G, Sievert W, Sperl J, Stärkel P, Stauber R, Thompson A, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Buti M, Calleja J, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R, Idilman R, Calinas F, Vogel W, Mendes Correa M, Hézode C, Lázaro P, Christensen P, Clausen M, Coelho H, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S, Hofer H, Frankova S, Ferreira P, Ferraz M, Cramp M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Falconer K, Félix J, Husa P. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014; 21 Suppl 1:34-59.
May 1, 2014The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:34-59
Kaita K D E, Nemecek V, Örmeci N, Øvrehus A L H, Parkes J, Pasini K, Peltekian K M, Ramji A, Reis N, Roberts S K, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R T, Marotta P, Mauss S, Rosenberg W M, Roudot-Thoraval F, Ryder S D, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela David, Sherman M, Shiha G E, Sievert W, Sperl J, Stärkel P, Stauber R E, Thompson A J, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Buti M, Calleja J L, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R P, Idilman R, Calinas F, Vogel W, Mendes Correa M C, Hézode C, Lázaro P, Christensen P B, Clausen M, Coelho H S M, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S J, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Cramp M E, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Falconer K, Félix J, Husa P
Historical epidemiology of hepatitis C virus (HCV) in selected countries
Kåberg M, Myers R, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M, Mauss S, Kaita K, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S, Rosenberg W, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela D, Shiha G, Sievert W, Stärkel P, Stauber R, Thompson A, Urbanek P, Hindman S, Idilman R, Bruggmann P, Bilodeau M, Blasco A, Buti M, Calinas F, Calleja J, Cheinquer H, Christensen P, Clausen M, Coelho H, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A, Moreno C, Brandão Mello C, Roudot-Thoraval F, Marinho R, Sherman M, Ryder S, Sperl J, Cornberg M, Cramp M, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P, Ferraz M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014; 21 Suppl 1:5-33.
May 1, 2014Historical epidemiology of hepatitis C virus (HCV) in selected countries
May 1, 2014J Viral Hepat 2014; 21 Suppl 1:5-33
Kåberg M, Myers R P, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M C, Mauss S, Kaita K D E, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S K, Rosenberg W M, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela David, Shiha G E, Sievert W, Stärkel P, Stauber R E, Thompson A J, Urbanek P, Hindman S J, Idilman R, Bruggmann P, Bilodeau M, Blasco A J, Buti M, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Clausen M, Coelho H S M, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A L H, Moreno C, Brandão Mello C E, Roudot-Thoraval F, Marinho R T, Sherman M, Ryder S D, Sperl J, Cornberg M, Cramp M E, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland
Overbeck K, Rickenbach M, Cerny A, Moradpur D, Heim M, Malinverni R, Borovicka J, Helbling B, Mullhaupt B, Dufour J, Negro F. Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland. Swiss Med Wkly 2010
Feb 3, 2010Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland
Feb 3, 2010Swiss Med Wkly 2010
Overbeck K, Rickenbach M, Cerny A, Moradpur D, Heim M, Malinverni R, Borovicka Jan, Helbling B, Mullhaupt B, Dufour J F, Negro F
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection
Helbling B, Mullhaupt B, Renner E, Rickenbach M, Bucher S, Negro F, Cerny A, Heim M, Borovicka J, Dufour J, Malinverni R, Gonvers J, Overbeck K, Swiss Hepatitis C Cohort Study. Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut 2008; 57:1597-603.
Nov 1, 2008Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection
Nov 1, 2008Gut 2008; 57:1597-603
Helbling B, Mullhaupt B, Renner E L, Rickenbach M, Bucher S, Negro F, Cerny A, Heim M, Borovicka Jan, Dufour J-F, Malinverni R, Gonvers J-J, Overbeck K, Swiss Hepatitis C Cohort Study